We wish to thank the following organizations that are participating as exhibitors.
The materials they provide are independent of the CME program and not part of the CME educational materials. These entities did not influence or determine the content of AAP Colorado’s 2026 Annual Conference. Participation in the exhibits is optional and encouraged.
a
To learn more about these exhibitors, please see their information below.
Action Behavior Centers (ABC) provides evidence-based applied behavior analysis (ABA) therapy for children with autism. As a leading pediatric ABA provider, ABC clinical leadership includes nationally recognized experts in patient-centered and innovative treatment approaches.
Our Early Intensive Behavioral Intervention (EIBI) services help children reach developmental goals across domains such as functional communication, behavior reduction, and adaptive living skills. Based on the principles of ABA therapy and backed by decades of research, EIBI promotes meaningful progress, generalization, and long-term skill maintenance.
With more than 40 Colorado locations and no waitlists, ABC gives families timely access to diagnostic support and individualized, pediatric ABA therapy. For questions or to refer a patient, contact our provider support team.
PH#: (720) 303-8480
Fax: (720) 596-5139
referrals@actionbehavior.com
Alpaca Health is a network of independent practices offering autism evaluation and ABA therapy across Colorado for ages 1–20. We meet families where they are — in homes, schools, daycares, and the community — with flexible, individualized care and no minimum hour requirements. We accept Medicaid, TRICARE, and most commercial plans and never have a waitlist. Referring is easy: We match your patient to the right provider. Fast intake, clear communication, statewide coverage. alpacahealth.io
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
Behavioral Innovations – Life Changing Autism Care for Children. When it comes to finding autism treatment for your child, we understand you have options. That’s why we do our best to ensure each family that walks through our doors experiences what sets us apart. Safe, reliable, and compassionate care you can count on from the moment you first contact us. Our promise to you is to be your trusted partner in this journey. Whether you are looking for autism testing or personalized Applied Behavior Analysis (ABA) therapy, we make it easy for you to get the help you and your child need. We are the only ABA provider to implement over two decades of successful outcomes into our thoughtful and proven treatment plans. Connect with our compassionate team to learn more: www.behavioral-innovations.com, 720-571-4796 Read family testimonials here!
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that offer new possibilities for people living with genetically defined conditions around the world. To learn more about our commitment to helping people with skeletal conditions, including achondroplasia, please visit www.biomarin.com/.
For more information contact Kirstie Hilty at kirstie.hilty@bmrn.com or (330)282-2096.
CeraVe and La Roche‑Posay together offer a comprehensive, dermatologist‑trusted approach to skincare. CeraVe strengthens the skin barrier with essential ceramides and long‑lasting hydration. La Roche‑Posay provides targeted solutions by balancing the skin’s microbiome using advanced active ingredients and soothing Thermal Spring Water. Used together, they create a balanced routine that supports both daily skin health and specific concerns. This dual‑branded solution delivers simple, effective care backed by dermatological science.
At Chiesi, we are making a rare difference. We strive to create a world where it is common to have a therapy for all diseases and we act as a force for good, for society and the planet. As a family business, we deliver innovative therapies and solutions for people affected by rare diseases. Our goal is to ensure equal access so as many people as possible can experience their most fulfilling life.
The Colorado Immunization Branch, at the Colorado Department of Public Health and Environment, works to reduce vaccine-preventable disease by developing and implementing programs designed to positively influence the uptake of immunizations across the lifespan. The Immunization Branch utilizes a variety of strategies to promote education, optimize vaccine resources, assure access to vaccines and maintain the Colorado Immunization Information System (CIIS), a confidential, population-based, computerized information system that collects and consolidates immunization data for Coloradans of all ages from a variety of sources and provides tools for designing and sustaining effective immunization strategies at the provider and program levels. The Immunization Branch also operates the Federal Vaccines for Children (VFC) program, the Federal Section 317 program, and all immunization education and outreach activities. Learn more by visiting the organization’s website here.
The Colorado Newborn Bloodspot Screening Program (CONBSP) aims to improve newborn’s lives through early detection of 39 life threatening genetic disorders for all Colorado and Wyoming newborns. CONBSP initially began testing for Phenylketonuria (PKU) in 1965. Annually, there are approximately 68,000 births in Colorado and Wyoming. Currently, there are requests that come from over 800 unique submitters. This translates into reporting more than 130,000 samples using 9 different testing methods for more than 700,000 individual tests annually. There are 700 affected children identified each year due to this testing. The CONBSP is required by statute to operate 6 days a week including holidays in order to ensure timely reporting of abnormal results. Babies with these conditions often appear normal at birth but could develop signs and symptoms later in life. CONBSP performs screening tests for all newborns on an opt out basis. All testing, reporting, education, and stakeholder engagement is performed by 21 full-time staff members. The program is cash funded provided by a one-time fee of $111.00 for each child tested. The program is a part of the Colorado State Public Health Laboratory within the Division of Disease Control and Public Health Response (DCPHR) at CDPHE.
Colorado Pediatric Psychiatry Consultation & Access Program (CoPPCAP) provides consultation at no cost to pediatric care providers by licensed child & adolescent psychiatrists, psychologists, and specialized community resource navigators. Learn more by watching their informative video here and visiting the organization’s website here. Contact: Kristin Larpenter, Info@coppcap.org, 1-888-910-0153.
The Colorado Perinatal Care Quality Collaborative (CPCQC) partners with healthcare and community organizations across the state to advance safe, equitable, and high-quality care for birthing people and infants. Through collaborative learning and data-driven quality improvement, CPCQC helps hospital teams implement evidence-based practices that improve outcomes for Colorado families. CPCQC’s infant-facing initiatives include Newborn Evidence-based Sleep Teaching (NEST), a statewide effort to strengthen safe sleep education and practices, and the upcoming Turning the Tide Dyadic Care Integration program, which will improve coordinated care for mother-infant pairs affected by substance use.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R & D capabilities, CSL Seqirus utilizes cell, adjuvant and egg technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
GSK unites science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines.
Healthy Young Minds is a Pediatric Behavioral and Mental Telehealth provider serving children, teens, and adults. We offer Counseling, Testing and Diagnosing, Speech, OT, ABA Therapy, case management, and Psychiatry (fall 2026). Our Masters and PhD level therapists are multilingual and multicultural. There is no waitlist, and we accept 100% of Colorado Medicaid and most commercial insurances.
JAG Institute provides groundbreaking research, education and training to help communities understand the magnitude of childhood bereavement and gain the evidence-based tools they need to address this growing issue. In partnership with the New York Life Foundation, the JAG Institute developed the Childhood Bereavement Estimation Model (CBEM) which approximates rates of U.S. children and youth who will experience the death of a parent or sibling by the time they reach adulthood using validated mortality data supplied by the Centers for Disease Control and Prevention. JAG Institute is the research division of Judi’s House, a nonprofit childhood bereavement center located in Aurora, Colo. that has served more than 16,000 children and caregivers grieving a death loss. To learn more, please visit: judishouse.org/jag-institute
At Sanofi, we are redefining immunology from science to treatment. Building on 100 years of expertise in diabetes, we are continuing to push scientific boundaries to improve our understanding of the immune system. We are dedicated to supporting and working with the type 1 diabetes community and use this collaboration as fuel to drive our mission to explore innovative therapies.
AAP Colorado’s Secure Their Future campaign provides free firearm cable locks and educational materials to pediatric health care clinics and the families they serve to help prevent firearm-related injuries and death. Learn more at SecureTheirFuture.org, or email SecureTheirFuture@aapcolorado.org with any questions about how to participate.
